Nutrition-Diabétologie, Centre Hospitalier de Bordeaux and Université de Bordeaux 2-Victor Segalen, Bordeaux 33000, France.
BMC Nephrol. 2010 Mar 3;11:3. doi: 10.1186/1471-2369-11-3.
Renal hypertrophy occurs early in diabetic nephropathy, its later value is unknown. Do large kidneys still predict poor outcome in patients with diabetes and Chronic Kidney Disease (CKD)?
Seventy-five patients with diabetes and CKD according to a Glomerular Filtration Rate (GFR, by 51Cr-EDTA clearance) below 60 mL/min/1.73 m2 or an Albumin Excretion Rate above 30 mg/24 H, had an ultrasound imaging of the kidneys and were cooperatively followed during five years by the Diabetology and Nephrology departments of the Centre Hospitalier Universitaire de Bordeaux.
The patients were mainly men (44/75), aged 62 +/- 13 yrs, with long-standing diabetes (duration:17 +/- 9 yrs, 55/75 type 2), and CKD: initial GFR: 56.5 (8.5-209) mL/min/1.73 m2, AER: 196 (20-2358) mg/24 H. Their mean kidney lenght (108 +/- 13 mm, 67-147) was correlated to the GFR (r = 0.23, p < 0.05). During the follow-up, 9/11 of the patients who had to start dialysis came from the half with the largest kidneys (LogRank: p < 0.05), despite a 40% higher initial isotopic GFR. Serum creatinine were initially lower (Small kidneys: 125 (79-320) micromol/L, Large: 103 (50-371), p < 0.05), but significantly increased in the "large kidneys" group at the end of the follow-up (Small kidneys: 129 (69-283) micromol/L, Large: 140 (50-952), p < 0.005 vs initial). The difference persisted in the patients with severe renal failure (KDOQI stages 4,5).
Large kidneys still predict progression in advanced CKD complicating diabetes. In these patients, ultrasound imaging not only excludes obstructive renal disease, but also provides information on the progression of the renal disease.
在糖尿病肾病中,肾脏肥大很早就会发生,但其后期的价值尚不清楚。那么,对于患有糖尿病和慢性肾脏病(CKD)的患者来说,大肾脏是否仍然预示着不良预后?
75 名患有糖尿病和 CKD 的患者,其肾小球滤过率(GFR,通过 51Cr-EDTA 清除率)低于 60 mL/min/1.73 m2 或白蛋白排泄率高于 30 mg/24 H,进行了肾脏超声成像,并由波尔多大学附属医院的糖尿病学和肾脏病学系在五年内进行合作随访。
患者主要为男性(44/75),年龄 62 +/- 13 岁,糖尿病病程较长(17 +/- 9 年,55/75 型 2 型),CKD:初始 GFR:56.5(8.5-209)mL/min/1.73 m2,AER:196(20-2358)mg/24 H。他们的平均肾脏长度(108 +/- 13 毫米,67-147)与 GFR 相关(r = 0.23,p < 0.05)。在随访期间,需要开始透析的 11 名患者中有 9 名来自肾脏最大的一半(LogRank:p < 0.05),尽管初始同位素 GFR 高出 40%。血清肌酐最初较低(小肾脏:125(79-320)μmol/L,大肾脏:103(50-371)μmol/L,p < 0.05),但在随访结束时“大肾脏”组的血清肌酐显著增加(小肾脏:129(69-283)μmol/L,大肾脏:140(50-952)μmol/L,p < 0.005 与初始值相比)。在严重肾衰竭(KDOQI 分期 4、5)患者中,这种差异仍然存在。
大肾脏仍然预示着糖尿病并发晚期 CKD 的进展。在这些患者中,超声成像不仅可以排除阻塞性肾病,还可以提供有关肾脏疾病进展的信息。